Misplaced Pages

Thromboxane B2: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 15:36, 12 May 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{chembox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (← Previous edit Latest revision as of 06:47, 10 September 2023 edit undoCrafterNova (talk | contribs)Extended confirmed users16,642 edits +synonymTag: 2017 wikitext editor 
(13 intermediate revisions by 12 users not shown)
Line 1: Line 1:
{{chembox {{chembox
| Verifiedfields = changed
| verifiedrevid = 411950829
| Watchedfields = changed
|ImageFile=Thromboxane B2.svg
| verifiedrevid = 428769862
|ImageSize=250px
| ImageFile=Thromboxane B2.svg
|ImageFileL2=ThromboxaneB2 spacefill.png
| ImageSize=250px
|ImageFileR2=ThromboxaneB2.png
| ImageFileL2=ThromboxaneB2 spacefill.png
|IUPACName=
| ImageFileR2=ThromboxaneB2.png
|OtherNames=
| PIN=(5''Z'')-7-<nowiki/>{(2''R'',3''S'',4''S'',6''Ξ'')-4,6-Dihydroxy-2-oxan-2-yl}hept-5-enoic acid
|Section1= {{Chembox Identifiers
| OtherNames=
| CASNo=54397-85-2
|Section1={{Chembox Identifiers
| PubChem=5283137
| CASNo_Ref = {{cascite|correct|??}}
| SMILES=
| CASNo=54397-85-2
| MeSHName=Thromboxane+B2
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = V94M3R26ZV
| PubChem=5283137
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 28728
| SMILES= CCCCC(O)\C=C\1OC(O)C(O)1C\C=C/CCCC(O)=O
| MeSHName=Thromboxane+B2
}} }}
|Section2= {{Chembox Properties |Section2={{Chembox Properties
| Formula=C<sub>20</sub>H<sub>34</sub>O<sub>6</sub> | Formula=C<sub>20</sub>H<sub>34</sub>O<sub>6</sub>
| MolarMass=370.48 g/mol | MolarMass=370.48 g/mol
| Appearance= | Appearance=
| Density= | Density=
| MeltingPt= | MeltingPt=
| BoilingPt= | BoilingPt=
| Solubility= | Solubility=
}} }}
|Section3= {{Chembox Hazards |Section3={{Chembox Hazards
| MainHazards= | MainHazards=
| FlashPt= | FlashPt=
| AutoignitionPt =
| Autoignition=
}} }}
}} }}
'''Thromboxane B2''' is an inactive metabolite/product of ]. It is almost completely cleared in the urine. '''Thromboxane B2''' ('''TXB2''') is an inactive metabolite/product of ]. It is almost completely cleared in the urine.


It itself is not involved in platelet activation and aggregation in case of a wound, but its precursor, thromboxane A2, is. Thromboxane A2 synthesis is the target of the drug ], which inhibits the ] enzyme (the source of thromboxane A2 in platelets). <ref name="urlDefinition: thromboxane b2 from Online Medical Dictionary">{{cite web |url=http://cancerweb.ncl.ac.uk/cgi-bin/omd?thromboxane+b2 |title=Definition: thromboxane b2 from Online Medical Dictionary |format= |work= |accessdate=2008-11-02}}</ref> It itself is not involved in platelet activation and aggregation in case of a wound, but its precursor, thromboxane A2, is. Thromboxane A2 synthesis is the target of the drug ], which inhibits the ] enzyme (the source of thromboxane A2 in platelets). <ref name="urlDefinition: thromboxane b2 from Online Medical Dictionary">{{cite web |url=http://cancerweb.ncl.ac.uk/cgi-bin/omd?thromboxane+b2 |title=Definition: thromboxane b2 from Online Medical Dictionary |format= |accessdate=2008-11-02}}</ref>


] (DHPE) is a phenolic component of ]. An olive oil fraction containing DHPE can inhibit ] and thromboxane B2 formation in vitro.<ref>Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Anna Petroni, Milena Blasevich, Marco Salami, Nadia Papini, Gian F. Montedoro and Claudio Gallia, ], 15 April 1995, Volume 78, Issue 2, Pages 151–160, {{doi|10.1016/0049-3848(95)00043-7}}</ref>
==References==

== References ==
{{reflist}} {{reflist}}


Thromboxane B2: Difference between revisions Add topic